The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.
The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.
A new journal that publishes peer review comments alongside its manuscripts goes live.
Why so few scientists make the leap to policy-making positions, and why more should give it a try
A retinal prosthesis, already available in Europe, can restore partial sight to people with a genetic disorder that causes blindness.
Globally, 15-year-old girls outscored boys in 43 of the 65 countries tested.
One of the most advanced tuberculosis vaccines has failed to protect infants from getting the disease in a clinical trial, but it may be effective in adults.
In Chapter 1, “A Theory,” author Aaron James constructs a working definition for the type of person that earns the ignominious moniker.
Harvard geneticists and anthropologists challenge the work of two economists who say there’s a link between genetic diversity and wealth.
A new study disputes findings of a 2011 analysis suggesting that black researchers are funded less than their equally qualified white peers.
The Science of Love, Bad Pharma, Genes, Cells and Brains, and Nature Wars